Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 12.35 -3.82% -0.49
BOLT closed down 3.82 percent on Friday, July 23, 2021, on 45 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical BOLT trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -3.82%
180 Bearish Setup Bearish Swing Setup -3.82%
Wide Bands Range Expansion -3.82%
MACD Bullish Signal Line Cross Bullish -11.02%
Older End-of-Day Signals for BOLT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 3 days ago
Down 3% 3 days ago
Up 3% 3 days ago
Down 2 % 3 days ago
Down 1% 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Products Cancer Immunotherapy Tumors Her2/Neu Immune Checkpoint Breast Cancers

Is BOLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 43.07
52 Week Low 12.33
Average Volume 188,217
200-Day Moving Average 0.00
50-Day Moving Average 15.96
20-Day Moving Average 14.33
10-Day Moving Average 13.43
Average True Range 0.97
ADX 40.24
+DI 7.45
-DI 28.78
Chandelier Exit (Long, 3 ATRs) 14.57
Chandelier Exit (Short, 3 ATRs) 15.24
Upper Bollinger Bands 16.68
Lower Bollinger Band 11.99
Percent B (%b) 0.08
BandWidth 32.69
MACD Line -1.01
MACD Signal Line -0.99
MACD Histogram -0.0248
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.70
Resistance 3 (R3) 13.84 13.54 13.48
Resistance 2 (R2) 13.54 13.19 13.47 13.40
Resistance 1 (R1) 12.94 12.98 12.79 12.80 13.32
Pivot Point 12.64 12.64 12.56 12.57 12.64
Support 1 (S1) 12.04 12.29 11.89 11.90 11.38
Support 2 (S2) 11.74 12.08 11.67 11.30
Support 3 (S3) 11.14 11.74 11.23
Support 4 (S4) 11.00